We are live on ! Find out more
SP

Summit Partners Portfolio holdings

AUM $609M
1-Year Est. Return 7.66%
This Fund
S&P 500
This Quarter Est. Return
+18.9%
1 Year Est. Return
+7.66%
3 Year Est. Return
+13.68%
5 Year Est. Return
-38.91%
10 Year Est. Return
+47.64%
AUM
$609M
AUM Growth
-$61.2M
Cap. Flow
-$99.2M
Cap. Flow %
-16.29%
Top 10 Hldgs %
100%
Holding
7
New
Increased
Reduced
2
Closed
2

Top Buys

No buys this quarter

Sector Composition

Rank Sector Weight
1 Technology 48.35%
2 Healthcare 41%
3 Consumer Discretionary 10.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KVYO icon
1
Klaviyo
KVYO
$5.63B
$285M 46.75%
18,852,778
LFST icon
2
Lifestance Health
LFST
$4.9B
$250M 41%
23,310,115
-5,899,661
-20% -$45.6M
AKA icon
3
a.k.a. Brands
AKA
$123M
$64.8M 10.65%
6,053,693
ATEN icon
4
A10 Networks
ATEN
$1.79B
$7.47M 1.23%
200,065
MTSI icon
5
MACOM Technology Solutions
MTSI
$19.9B
$2.28M 0.38%
6,005
-43,268
-88% -$14.4M
AVAH icon
6
Aveanna Healthcare
AVAH
$2.98B
-5,451,422
Closed -$35.1M
SBDS
7
DELISTED
Solo Brands Inc
SBDS
-1,100,870
Closed -$4.14M

Similar funds

Summit Partners's Q2 2026 Portfolio in Review

As of Q2 2026, Summit Partners held 7 positions worth $609M, down 9.1% from $670M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Summit Partners withdrew a net $99.2M in Q2 2026, closing 2 positions and reducing 2 holdings. Its most notable exit was Aveanna Healthcare, an estimated $35.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 48% of assets, down from 57% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Summit Partners's biggest Q2 2026 reduction was Lifestance Health, cutting an estimated $45.6M.
  • Summit Partners fully exited Aveanna Healthcare in Q2 2026, selling an estimated $35.1M.
  • Summit Partners's ten largest holdings make up 100% of its $609M portfolio in Q2 2026.
  • Summit Partners opened 0 new positions and closed 2 in Q2 2026.
  • Summit Partners's portfolio value fell 9.1% quarter-over-quarter to $609M.

Based on Summit Partners's 13F filing for Q2 2026, filed 30 Jul 2026.